| Nome do produto |
Erythromycin lactobionate |
| Nome em inglês |
Erythromycin lactobionate; 4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin; Erythrocin Lactobionate IV; Erythromycin lactobionate (1:1) (salt); Erythromycin mono(4-O-beta-D-galactopyranosyl-D-gluconate) (salt); Erythromycin. compd. with lactobionic acid; D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1) (9CI); Erythromycin, 4-O-beta-D-galactopyranosyl-D-gluconate (salt); Lactobionic acid, compd. with erythromycin (1:1); (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}hexanoic acid - (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (1:1) (non-preferred name) |
| Fórmula molecular |
C49H89NO25 |
| Peso Molecular |
1092.2227 |
| InChI |
InChI=1/C37H67NO13.C12H22O12/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;13-1-3(15)10(7(18)8(19)11(21)22)24-12-9(20)6(17)5(16)4(2-14)23-12/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;3-10,12-20H,1-2H2,(H,21,22)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;3-,4-,5+,6+,7-,8-,9-,10-,12+/m11/s1 |
| CAS Registry Number |
3847-29-8 |
| EINECS |
223-348-7 |
| Estrutura Molecular |
|
| Ponto de ebuli??o |
818.4°C at 760 mmHg |
| O ponto de inflama??o |
448.8°C |
| Press?o de vapor |
4.94E-31mmHg at 25°C |
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descri??o da Seguran?a |
|
|
PT
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
RU
SA
TR
